市场调查报告书
商品编码
1518619
2024-2032 年紧急避孕药市场报告(按类型(复方药丸、黄体酮药丸等)、配销通路(零售店、线上商店等)和地区Emergency Contraceptive Pills Market Report by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2024-2032 |
IMARC Group年,全球紧急避孕药市场规模达到5.859亿美元。大众对避孕和计划生育的认识不断提高、政府和非政府组织(NGO)支持政策的实施以及非荷尔蒙紧急避孕药的最新发展是推动市场的一些关键因素。
紧急避孕药(ECP)是指用于预防意外怀孕的避孕药。它们是用合成荷尔蒙製造的,例如左炔诺孕酮,它可以延迟排卵,改变子宫内膜,并防止卵子受精。 ECP 广泛用于传统避孕方法失败期间、无保护性交后、作为缺乏常规避孕药的备用药物以及性侵犯犯罪的受害者。它们是安全、经济有效、容易取得且非常方便的药物,不会导致长期生育问题,可成功预防意外怀孕,并消除堕胎的需要。 ECP 还可以更好地控制生殖健康,赋予妇女权力,减少焦虑和压力,并最大限度地减少副作用。
群众避孕和计划生育意识的增强是推动市场成长的关键因素之一。 ECP 作为一种安全、方便且高度舒适的紧急避孕方式被女性广泛使用,可防止意外怀孕、保护隐私并最大限度地降低副作用和未来併发症的风险。除此之外,由于无保护性交和性侵犯导致的意外怀孕发生率上升,产品的广泛使用也是另一个促进成长的因素。此外,政府和非政府组织(NGO)实施支持性政策,以传播意识、教育大众并提供方便的紧急避孕药具,正在对市场成长产生积极影响。此外,最近开发的非荷尔蒙ECP 也为市场成长提供了动力,其中含有醋酸乌利司他,可阻断体内黄体酮受体,并且与传统的左炔诺孕酮药物相比,产生的副作用更少。除此之外,由于全球范围内对女性健康和福祉的日益关注,产品采用率不断上升,有利于市场成长。除此之外,对不需要处方且女性在紧急情况下可以轻鬆获得的非处方(OTC)产品的需求不断增长,也支撑了市场的成长。此外,製造商透过社群媒体、有影响力的行销、电视广告和名人代言积极的促销和品牌活动也促进了市场的成长。其他因素,包括消费者支出能力的提高、广泛的研发 (R&D) 活动以及跨电子商务平台的便利产品供应,预计将推动市场成长。
The global emergency contraceptive pills market size reached US$ 585.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 814.3 Million by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The increasing awareness among the masses regarding contraception and family planning, the implementation of supportive policies by governments and non-governmental organizations (NGOs), and the recent development of non-hormonal ECPs represent some of the key factors driving the market.
Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions. ECPs also provide better control over reproductive health, empower women, reduce anxiety and stress, and minimize side effects.
The increasing awareness among the masses regarding contraception and family planning is one of the key factors propelling the market growth. ECPs are widely used by women as a safe, convenient, and highly comfortable form of emergency contraception, which prevents unwanted pregnancies, maintains privacy, and minimizes the risks of side effects and future complications. Along with this, the widespread product utilization due to rising incidences of unintended pregnancies owing to unprotected intercourse and sexual assault is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governments and non-governmental organizations (NGOs) to spread awareness, educate the masses, and provide easy access to emergency contraception is positively influencing the market growth. Additionally, the recent development of non-hormonal ECPs, which contains ulipristal acetate that blocks progesterone receptors in the body and produces fewer side effects compared to traditional levonorgestrel-based pills, is providing an impetus to the market growth. Apart from this, the rising product adoption owing to the increasing focus on women's health and well-being across the globe is favoring the market growth. Besides this, the growing demand for over-the-counter (OTC) products that don't require prescriptions and can be easily accessed by women in case of emergency is supporting the market growth. Moreover, aggressive promotional and branding campaigns by manufacturers through social media, influencer marketing, television (TV) commercials, and celebrity endorsement are contributing to the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and easy product availability across e-commerce platforms, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global emergency contraceptive pills market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type and distribution channel.
Combination Pills
Progesterone Pills
Others
The report has provided a detailed breakup and analysis of the emergency contraceptive pills market based on the type. This includes combination pills, progesterone pills, and others. According to the report, combination pills represented the largest segment.
Retail Stores
Online Stores
Others
A detailed breakup and analysis of the emergency contraceptive pills market based on the distribution channel has also been provided in the report. This includes retail stores, online stores, and others. According to the report, retail stores accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emergency contraceptive pills. Some of the factors driving the North America emergency contraceptive pills market included the increasing awareness regarding women's health, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global emergency contraceptive pills market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.